Definition
Decreased circulating RBC mass (indicated by low PCV, hemoglobin, and total RBC count) accompanied by appropriate, compensatory increase in RBC production by the bone marrow (e.g., reticulocytosis in the peripheral blood and RBC hyperplasia in the bone marrow).
Pathophysiology
Systems Affected
Signalment
Signs
Causes
Immune Mediated
Oxidant Injury
Erythrocyte Parasites
Mechanical RBC Fragmentation
Inherited RBC Abnormalities
Hypophosphatemia
Severe hypophosphatemia, secondary to treatment with insulin or phosphate binders, impairs ATP production, leading to increased erythrocyte fragility and hemolysis.
Blood Loss
Differential Diagnosis
Differentiated from nonregenerative anemia by high reticulocyte count.
Laboratory Findings
Disorders That May Alter Laboratory Results
Valid If Run in Human Laboratory?
CBC/Biochemistry/Urinalysis
Other Laboratory Tests
Diagnostic Procedures
Blood Loss Anemias
Hemolytic Anemias
Blood transfusion may be indicated; in patients with immune-mediated process, RBCs probably survive similarly to patient's own RBCs, so transfusion should not be withheld if marked signs of anemia present.
Drug(s)
Patient Monitoring
See Also
Abbreviations
Internet Resources
Erythrocytes: Overview, Morphology, Quantity; A.H. Rebar, P.S. MacWilliams, B.F. Feldman, et al.: http://www.ivis.org/advances/Rebar/Chap4/chapter.asp?LA=1.
Suggested Reading
Immune-mediated haemolytic anemia and other regenerative anemias. In: Ettinger SJ, Feldman EC, eds., Textbook of Veterinary Internal Medicine: Diseases of the Dog and Cat, 7th ed.St Louis, MO: Elsevier Saunders, 2010, pp. 761772.
, .Author Joyce S. Knoll
Consulting Editor Alan H. Rebar